Product News

AmantadineHydrochloride USPCapsules

Marketed by:

Banner Pharmacaps Inc(High Point, NC)

Compared to:

Amantadine Hydrochloride(USL Pharma)

Indication:

June 2, 2008—Banner Pharmacaps Inc announcedthat the FDA approved its Abbreviated New DrugApplication for Amantadine Hydrochloride USP 100-mgsoft gelatin capsules. Amantadine is indicated for theprophylaxis and treatment of signs and symptoms ofinfection in the respiratory tract caused by variousstrains of influenza A virus. Amantadine also is used inthe treatment of Parkinson's disease and drug-inducedextrapyramidal reactions.

Dosage Form:

Capsules: 100 mg

For More Information:

www.banpharm.com

Lamotrigine Tablets

Marketed by:

Teva Pharmaceuticals(North Wales, PA)

Compared to:

Lamictal Tablets(GlaxoSmithKline)

Indication:

July 22, 2008—TevaPharmaceuticals announced the introduction and availabilityof Lamotrigine Tablets. Lamotrigine Tablets areindicated as adjunctive therapy for partial seizures andthe generalized seizures of Lennox?Gastaut syndromein adults and pediatric patients (=2 years of age). Thetablets also are indicated for conversion to monotherapyin adults with partial seizures who are receivingtreatment with carbamazepine, phenytoin, phenobarbital,primidone, or valproate as the single antiepilepticdrug. Lamotrigine also is indicated for the maintenancetreatment of bipolar I disorder.

Dosage Form:

Tablets: 25, 100, 150, and 200 mg

For More Information:

www.tevausa.com888-TEVA USA (888-838-2872)

Meclizine HCl Tablets

Marketed by:

Par Pharmaceutical Companies Inc(Woodcliff Lake, NJ)

Compared to:

Antivert (Pfizer Inc)

Indication:

July 9, 2008—Par Pharmaceutical Companies Incannounced that it began shipment of 12.5- and 25-mgMeclizine HCl Tablets. Meclizine is an oral antiemeticindicated for the prevention and treatment of nausea,vomiting, and dizziness associated with motion sickness.It is contraindicated in individuals who haveshown a previous hypersensitivity to it. The initial doseof 25 to 50 mg Meclizine HCl should be taken 1 hourprior to travel for protection against motion sickness.Thereafter, the dose may be repeated every 24 hoursfor the duration of the journey.

Dosage Form:

Tablets: 12.5 and 25 mg

For More Information:www.parpharm.com

PotassiumChlorideExtendedreleaseCapsules

Marketed by:

Watson Pharmaceuticals Inc (Corona, CA)

Compared to:

Micro-K Extencaps USP (KV Pharmaceutical)

Indication:

June 3, 2008—Watson Pharmaceuticals announcedthat it received approval from the FDA for itsAbbreviated New Drug Application for PotassiumChloride Extended-release Capsules USP in 8- and10-mEq strengths. Potassium chloride is indicated forthe treatment of patients with hypokalemia, with orwithout metabolic alkalosis, in digitalis intoxications,and in patients with hypokalemic familial periodicparalysis.

Dosage Form:

Capsules: 8 and 10 mEq

For More Information:www.watson.com